Utilizing a mouse model of GWI, researchers examined the potential of β-adrenergic (beta-adrenergic) receptor inhibitor and anti-inflammatory drug, propranolol, as a treatment for GWI. Findings indicate that anti-neuroinflammatory drugs, such as proranolol, show promising potential in treating the underlying neuroimmune issues associated with GWI.
Mouse or rat models of Gulf War Illness are commonly used prior to human experimentation. Abstracts of some recent studies utilizing a mouse model of GWI are linked below. Prolonged Antibiotic Use Worsens Neuroinflammation and Increases the Risk of Neurodegeneration via Elevated Expression of Systemic IL-6 in Gulf War Illness Symptom Persistence Murine Model Nexinhib […]
This study utilized Positron Emission Tomography (PET) to examine neuroinflammatory markers in Gulf War veterans. The findings of this study support further investigation into the role of neuroinflammation in Gulf War Illness.